New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 30, 2014
06:20 EDTDOXAmdocs upgraded to Outperform from Perform at Oppenheimer
Oppenheimer upgraded Amdocs with a $47 price target citing the company's solid Q1 results and slightly improved FY14 guidance. Opco says the stock tends to outperform in uncertain market conditions.
News For DOX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 2, 2015
16:08 EDTDOXAmdocs sees Comverse BSS assets acquisition neutral to EPS in first year
Amdocs announced that it has completed the acquisition of a substantial majority of Comverse's business support systems, or BSS, business unit assets, for approximately $273M in cash, including its converged, prepaid, postpaid and Kenan billing assets. The acquisition geographically complements Amdocs' existing activities by expanding and diversifying the company's global customer base, particularly in Europe, Asia-Pacific and Latin America, where Comverse has a wide BSS customer footprint. Consistent with guidance provided on April 29, Amdocs expects the acquisition of the Comverse BSS assets to contribute revenue in the low tens of millions of dollars for the first couple of quarters after closing. The impact of the acquisition on Amdocs' diluted non-GAAP EPS is expected to be neutral in the first year after closing and accretive thereafter. The impact on diluted GAAP EPS will be finalized after Amdocs completes the purchase price allocation. Amdocs expects to incur acquisition-related expenses related to operating adjustments, restructuring charges and other acquisition-related costs.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use